FDA recommends no changes to Lilly's schizophrenia injection use
March 23, 2015 at 14:32 PM EDT
March 23 (Reuters) - The U.S. Food and Drug Administration said it would not recommend changes to the prescribing or use of Eli Lilly and Co's schizophrenia drug after a review of two deaths.
